Cargando…

Gene expression pattern of the epidermal growth factor receptor family and LRIG1 in renal cell carcinoma

BACKGROUND: Previous studies have revealed altered expression of epidermal growth factor receptor (EGFR)-family members and their endogenous inhibitor leucine-rich and immunoglobulin-like domains 1 (LRIG1) in renal cell carcinoma (RCC). In this study, we analyzed the gene expression levels of EGFR-f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thomasson, Marcus, Hedman, Håkan, Ljungberg, Börje, Henriksson, Roger
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419632/ https://www.ncbi.nlm.nih.gov/pubmed/22554477 http://dx.doi.org/10.1186/1756-0500-5-216

Ejemplares similares

LRIG1 and epidermal growth factor receptor in renal cell carcinoma: a quantitative RT–PCR and immunohistochemical analysis
por: Thomasson, M, et al.
Publicado: (2003)

LRIG1 and epidermal growth factor receptor in renal cell carcinoma: a quantitative RT–RCR and immunohistochemical analysis
por: Thomasson, M, et al.
Publicado: (2004)

LRIG and cancer prognosis
por: Lindquist, David, et al.
Publicado: (2014)

A protein interaction network centered on leucine-rich repeats and immunoglobulin-like domains 1 (LRIG1) regulates growth factor receptors
por: Faraz, Mahmood, et al.
Publicado: (2018)

Lrig2-Deficient Mice Are Protected against PDGFB-Induced Glioma
por: Rondahl, Veronica, et al.
Publicado: (2013)

Co-incidental increase in gene copy number of ERBB2 and LRIG1 in breast cancer
por: Ljuslinder, Ingrid, et al.
Publicado: (2009)

Lrig1 is a haploinsufficient tumor suppressor gene in malignant glioma
por: Mao, Feng, et al.
Publicado: (2018)

LRIG1 negatively regulates RET mutants and is downregulated in thyroid cancer
por: Lindquist, David, et al.
Publicado: (2018)

LRIG1 gene copy number analysis by ddPCR and correlations to clinical factors in breast cancer
por: Faraz, Mahmood, et al.
Publicado: (2020)

Lrig2 and Hpse2, mutated in urofacial syndrome, pattern nerves in the urinary bladder
por: Roberts, Neil A., et al.
Publicado: (2019)

HYPOTHESIS: Do LRIG Proteins Regulate Stem Cell Quiescence by Promoting BMP Signaling?
por: Herdenberg, Carl, et al.
Publicado: (2022)

Expression of LRIG1 is associated with good prognosis and human papillomavirus status in oropharyngeal cancer
por: Lindquist, D, et al.
Publicado: (2014)

Expression of LRIG proteins as possible prognostic factors in primary vaginal carcinoma
por: Ranhem, Cecilia, et al.
Publicado: (2017)

Gas6 and the Receptor Tyrosine Kinase Axl in Clear Cell Renal Cell Carcinoma
por: Gustafsson, Anna, et al.
Publicado: (2009)

LRIG proteins regulate lipid metabolism via BMP signaling and affect the risk of type 2 diabetes
por: Herdenberg, Carl, et al.
Publicado: (2021)

The soluble form of the tumor suppressor Lrig1 potently inhibits in vivo glioma growth irrespective of EGF receptor status
por: Johansson, Mikael, et al.
Publicado: (2013)

Identification and validation of NFIA as a novel prognostic marker in renal cell carcinoma
por: de Alwis, Roger, et al.
Publicado: (2023)

LRIG1 is a conserved EGFR regulator involved in melanoma development, survival and treatment resistance
por: Billing, Ola, et al.
Publicado: (2021)

Transforming growth factor-β promotes aggressiveness and invasion of clear cell renal cell carcinoma
por: Sitaram, Raviprakash T., et al.
Publicado: (2016)

VHL status regulates transforming growth factor-β signaling pathways in renal cell carcinoma
por: Mallikarjuna, Pramod, et al.
Publicado: (2018)

The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma
por: Cheng, Fangling, et al.
Publicado: (2019)

LRIG1-2 and LMO7 immunoreactivity in vulvar squamous cell carcinoma: Association with prognosis in relation to HPV-DNA and p16(INK4a) status
por: Stefansson, Kristina, et al.
Publicado: (2019)

Increased copy number at 3p14 in breast cancer
por: Ljuslinder, Ingrid, et al.
Publicado: (2005)

Correction: Increased copy number at 3p14 in breast cancer
por: Ljuslinder, Ingrid, et al.
Publicado: (2006)

Corrigendum: The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma
por: Cheng, Fangling, et al.
Publicado: (2020)

Lrig1-expressing epidermal progenitors require SCD1 to maintain the dermal papilla niche
por: Lim, Sophia Beng Hui, et al.
Publicado: (2023)

Progress in survival in renal cell carcinoma through 50 years evaluated in Finland and Sweden
por: Hemminki, Kari, et al.
Publicado: (2021)

WNT and NOTCH signaling pathways as activators for epidermal growth factor receptor in esophageal squamous cell carcinoma
por: Abbaszadegan, Mohammad Reza, et al.
Publicado: (2018)

Lrig1 is a positive prognostic marker in hepatocellular carcinoma
por: Yang, Bo, et al.
Publicado: (2016)

Specific Genomic Aberrations Predict Survival, But Low Mutation Rate in Cancer Hot Spots, in Clear Cell Renal Cell Carcinoma
por: Köhn, Linda, et al.
Publicado: (2015)

Telomere Length in Relation to Immunological Parameters in Patients with Renal Cell Carcinoma
por: Svenson, Ulrika, et al.
Publicado: (2013)

Cancer Characteristics and Current Treatments of Patients with Renal Cell Carcinoma in Sweden
por: Thorstenson, Andreas, et al.
Publicado: (2015)

The Notch and TGF-β Signaling Pathways Contribute to the Aggressiveness of Clear Cell Renal Cell Carcinoma
por: Sjölund, Jonas, et al.
Publicado: (2011)

Interactions between TGF-β type I receptor and hypoxia-inducible factor-α mediates a synergistic crosstalk leading to poor prognosis for patients with clear cell renal cell carcinoma
por: Mallikarjuna, Pramod, et al.
Publicado: (2019)

Author Correction: Lrig1-expressing epidermal progenitors require SCD1 to maintain the dermal papilla niche
por: Lim, Sophia Beng Hui, et al.
Publicado: (2023)

Gene Expression Profiling Predicts Survival in Conventional Renal Cell Carcinoma
por: Zhao, Hongjuan, et al.
Publicado: (2006)

Assessment of Epidermal Growth Factor Receptor (EGFR) expression in human meningioma
por: Wernicke, A Gabriella, et al.
Publicado: (2010)

Single Nucleotide Polymorphisms in the Wilms’ Tumour Gene 1 in Clear Cell Renal Cell Carcinoma
por: Li, Xingru, et al.
Publicado: (2013)

A psychometric evaluation of the Functional assessment of cancer therapy—kidney symptom index (FKSI-19) among renal cell carcinoma patients suggesting an alternative two-factor structure
por: Rosenblad, Andreas Karlsson, et al.
Publicado: (2021)

High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal oncocytomas
por: Yusenko, Maria V, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_3kbnmkisc99ei20bcesk2crf8u